The role of the low-density lipoprotein receptor–related protein 1 (LRP-1) in regulating blood-brain barrier integrity

References

Abbott, N.J. (2005). Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25, 5–23.10.1007/s10571-004-1374-ySuche in Google Scholar PubMed

Abbott, N.J., Patabendige, A.A.K., and Dolman, D.E.M. (2010). Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13–25.10.1016/j.nbd.2009.07.030Suche in Google Scholar PubMed

Abuznait, A.H., Qosa, H., and Busnena, B.A. (2013). Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies. ACS Chem. Neurosci. 4, 973–982.10.1021/cn400024qSuche in Google Scholar PubMed PubMed Central

An, J., Zhang, C., and Polavarapu, R. (2008). Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 112, 2787–2794.10.1182/blood-2008-02-141630Suche in Google Scholar PubMed PubMed Central

Andras, I.E., Eum, S.Y., and Huang, W. (2010). HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin. Mol. Cell. Neurosci. 43, 232–243.10.1016/j.mcn.2009.11.004Suche in Google Scholar PubMed PubMed Central

Asahi, M., Wang, X.Y., and Mori, T. (2001). Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724–7732.10.1523/JNEUROSCI.21-19-07724.2001Suche in Google Scholar

Bachmeier, C., Beaulieu-Abdelahad, D., and Mullan, M. (2013). Role of the cannabinoid system in the transit of β-amyloid across the blood-brain barrier. Mol. Cell. Neurosci. 56, 255–262.10.1016/j.mcn.2013.06.004Suche in Google Scholar PubMed

Baeten, K.M. and Akassoglou, K. (2011). Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev. Neurobiol. 71, 1018–1039.10.1002/dneu.20954Suche in Google Scholar PubMed PubMed Central

Ballabh, P., Braun, A., and Nedergaard, M. (2004). The blood-brain barrier: an overview — structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1–13.10.1016/j.nbd.2003.12.016Suche in Google Scholar PubMed

Barmina, O.Y., Walling, H.W., and Fiacco, G.J. (1999). Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J. Biol. Chem. 274, 30087–30093.10.1074/jbc.274.42.30087Suche in Google Scholar PubMed

Basak, J.M., Kim, J., and Holtzman, D.M. (2010). Overexpression of the LDL receptor increases the metabolism of apoE and Aβ by primary cultured astroglial cells. Society for Neuroscience Abstract Viewer and Itinerary Planner 40, BCI: BCI201100537195.Suche in Google Scholar

Bauer, A.T., Burgers, H.F., and Rabie, T. (2010). Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 30, 837–848.10.1038/jcbfm.2009.248Suche in Google Scholar

Bell, R.D., Sagare, A.P., and Friedman, A.E. (2007). Transport pathways for clearance of human Alzheimer’s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 27, 909–918.10.1038/sj.jcbfm.9600419Suche in Google Scholar

Bell, R.D., Winkler, E.A., and Singh, I. (2012). Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512–516.10.1038/nature11087Suche in Google Scholar

Bellail, A.C., Hunter, S.B., and Brat, D.J. (2004). Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol. 36, 1046–1069.10.1016/j.biocel.2004.01.013Suche in Google Scholar

Bertrand, Y., Currie, J.C., and Poirier, J. (2011). Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1. Br. J. Cancer. 105, 1697–1707.10.1038/bjc.2011.427Suche in Google Scholar

Biron, K.E., Dickstein, D.L., and Gopaul, R. (2011). Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer’s disease. PLoS One 6, e23789.10.1371/journal.pone.0023789Suche in Google Scholar

Brkic, M., Balusu, S., Van Wonterghem, E., Gorlé, N., Benilova, I., Kremer, A., Van Hove, I., Moons, L., De Strooper, B., Kanazir, S., et al. (2015). Amyloid beta oligomers disrupt blood-csf barrier integrity by activating matrix metalloproteinases. J. Neurosci. 35, 12766–12778.10.1523/JNEUROSCI.0006-15.2015Suche in Google Scholar

Bu, G.J. (2009). Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 10, 333–344.10.1038/nrn2620Suche in Google Scholar

Butterfield, D.A., Drake, J., and Pocernich, C. (2001). Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid β-peptide. Trends Mol. Med. 7, 548–554.10.1016/S1471-4914(01)02173-6Suche in Google Scholar

Caceres, L.C., Bonacci, G.R., and Sanchez, M.C. (2010). Activated α2 macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF-κB activation in macrophage-derived cell lines. J. Cell. Biochem. 111, 607–617.10.1002/jcb.22737Suche in Google Scholar PubMed

Cao, L.N., Wang, H., and Wang, F. (2013). Amyloid-β-induced matrix metalloproteinase-9 secretion is associated with retinal pigment epithelial barrier disruption. Int. J. Mol. Med. 31, 1105–1112.10.3892/ijmm.2013.1310Suche in Google Scholar

Carrano, A., Hoozemans, J.J.M., and van der Vies, S.M. (2011). Amyloid β induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid. Redox Signal. 15, 1167–1178.10.1089/ars.2011.3895Suche in Google Scholar

Chang, C. and Werb, Z. (2001). The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11, S37–S43.10.1016/S0962-8924(01)02122-5Suche in Google Scholar

Che, C., Yang, G.Q., and Thiot, C. (2010). New angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration. J. Med. Chem. 53, 2814–2824.10.1021/jm9016637Suche in Google Scholar PubMed

Chevronnay, H.P.G., Selvais, C., and Emonard, H. (2012). Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. BBA Proteins Proteomics. 1824, 146–156.10.1016/j.bbapap.2011.09.003Suche in Google Scholar PubMed

Corder, E.H., Saunders, A.M., and Strittmatter, W.J. (1993). Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimers disease in late-onset families. Science 261, 921–923.10.1126/science.8346443Suche in Google Scholar PubMed

Davis, F.M., Rateri, D.L., and Balakrishnan, A. (2015). Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 35, 155–162.10.1161/ATVBAHA.114.304683Suche in Google Scholar PubMed PubMed Central

Deane, R., Wu, Z.H., and Sagare, A. (2004). LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 43, 333–344.10.1016/j.neuron.2004.07.017Suche in Google Scholar PubMed

Demeule, M., Currie, J.C., and Bertrand, Y. (2008). Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2. J. Neurochem. 106, 1534–1544.10.1111/j.1471-4159.2008.05492.xSuche in Google Scholar PubMed

Deryugina, E.I. and Quigley, J.P. (2012). Cell surface remodeling by plasmin: a new function for an old enzyme. J. Biomed. Biotechnol. 2012, 564259.10.1155/2012/564259Suche in Google Scholar PubMed PubMed Central

Desrosiers, R.R., Rivard, M.E., and Grundy, P.E. (2006). Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Pediatr. Blood Cancer 46, 40–49.10.1002/pbc.20566Suche in Google Scholar PubMed

Do, T.M., Dodacki, A., and Alata, W. (2016). Age–dependent regulation of the blood-brain barrier influx/efflux equilibrium of amyloid-β peptide in a mouse model of Alzheimer’s disease (3xTg-AD). J. Alzheimers Dis. 49, 287–300.10.3233/JAD-150350Suche in Google Scholar PubMed

Donahue, J.E. and Johanson, C.E. (2008). Apolipoprotein E, amyloid-β, and blood-brain barrier permeability in Alzheimer disease. J. Neuropathol. Exp. Neurol. 67, 261–270.10.1097/NEN.0b013e31816a0dc8Suche in Google Scholar PubMed

Emonard, H., Bellon, G., and Troeberg, L. (2004). Low density lipoprotein receptor-related protein mediates endocytic clearance of Pro-MMP-2 center dot TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 279, 54944–54951.10.1074/jbc.M406792200Suche in Google Scholar PubMed

Erickson, M.A. and Banks, W.A. (2013). Blood-brain barrier dysfunction as a cause and consequence of Alzheimer’s disease. J. Cereb. Blood Flow Metab. 33, 1500–1513.10.1038/jcbfm.2013.135Suche in Google Scholar PubMed PubMed Central

Erickson, M.A., Hansen, K., and Banks, W.A. (2012). Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine. Brain Behav. Immun. 26, 1085–1094.10.1016/j.bbi.2012.07.003Suche in Google Scholar PubMed PubMed Central

Etique, N., Verzeaux, L., and Dedieu, S. (2013). LRP-1: a checkpoint for the extracellular matrix proteolysis. Biomed Res. Int. 2013, 152163.10.1155/2013/152163Suche in Google Scholar PubMed PubMed Central

Fayard, B., Bianchi, F., and Dey, J. (2009). The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res. 69, 5690–5698.10.1158/0008-5472.CAN-08-4573Suche in Google Scholar PubMed

Fiala, M., Liu, Q.N., and Sayre, J. (2002). Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest. 32, 360–371.10.1046/j.1365-2362.2002.00994.xSuche in Google Scholar PubMed

Fullerton, S.M., Shirman, G.A., and Strittmatter, W.J. (2001). Impairment of the blood-nerve and blood-brain barriers in apolipoprotein E knockout mice. Exp. Neurol. 169, 13–22.10.1006/exnr.2001.7631Suche in Google Scholar PubMed

Galora, S., Saracini, C., and Pratesi, G. (2015). Association of rs1466535 LRP1 but not rs3019885 SLC30A8 and rs6674171 TDRD10 gene polymorphisms with abdominal aortic aneurysm in Italian patients. J. Vasc. Surg. 61, 787–792.10.1016/j.jvs.2013.10.090Suche in Google Scholar PubMed

Gaultier, A., Hollister, M., and Reynolds, I. (2010). LRP1 regulates remodeling of the extracellular matrix by fibroblasts. Matrix Biol. 29, 22–30.10.1016/j.matbio.2009.08.003Suche in Google Scholar PubMed PubMed Central

Gheorghiu, M., Enciu, A.M., and Popescu, B.O. (2014). Functional and molecular characterization of the effect of amyloid-β(42) on an in vitro epithelial barrier model. J. Alzheimers Dis. 38, 787–798.10.3233/JAD-122374Suche in Google Scholar PubMed

Giusti, B., Galora, S., and Saracini, C. (2014). Role of rs1466535 low density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism in carotid artery disease. Atherosclerosis 237, 135–137.10.1016/j.atherosclerosis.2014.08.049Suche in Google Scholar PubMed

Gonias, S.L. and Campana, W.M. (2014). LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. Am. J. Pathol. 184, 18–27.10.1016/j.ajpath.2013.08.029Suche in Google Scholar PubMed PubMed Central

Gonzalez-Velasquez, F.J., Reed, J.W., and Fuseler, J.W. (2010). Soluble amyloid-β protein aggregates induce nuclear factor-κB mediated upregulation of adhesion molecule expression to stimulate brain endothelium for monocyte adhesion. J. Adhes. Sci. Technol. 24, 2105–2126.10.1163/016942410X507948Suche in Google Scholar

Gonzalez-Velasquez, F.J., Reed, J.W., and Fuseler, J.W. (2011). Activation of brain endothelium by soluble aggregates of the amyloid-β protein involves nuclear factor-κB. Curr. Alzheimer Res. 8, 81–94.10.2174/156720511794604606Suche in Google Scholar PubMed

Grimmer, T., Goldhardt, O., and Guo, L.H. (2014). LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer’s disease in humans in vivo. NeuroImage Clin. 4, 411–416.10.1016/j.nicl.2014.01.016Suche in Google Scholar PubMed PubMed Central

Hafezi-Moghadam, A., Thomas, K.L., and Wagner, D.D. (2007). ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. Am. J. Physiol. Cell Physiol. 292, C1256–C1262.10.1152/ajpcell.00563.2005Suche in Google Scholar PubMed

Hahn-Dantona, E., Ruiz, J.F., and Bornstein, P. (2001). The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276, 15498–15503.10.1074/jbc.M100121200Suche in Google Scholar PubMed

Halliday, M.R., Rege, S.V., and Ma, Q.Y. (2016). Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J. Cereb. Blood Flow Metab. 36, 216–227.10.1038/jcbfm.2015.44Suche in Google Scholar PubMed PubMed Central

Hartz, A.M.S., Bauer, B., and Soldner, E.L.B. (2012). Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43, 514–523.10.1161/STROKEAHA.111.627562Suche in Google Scholar PubMed PubMed Central

Hawkins, B.T., Lundeen, T.F., and Norwood, K.M. (2007). Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50, 202–211.10.1007/s00125-006-0485-zSuche in Google Scholar PubMed

Herz, J. and Strickland, D.K. (2001). LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779–784.10.1172/JCI200113992Suche in Google Scholar

Hu, K.B., Yang, J.W., and Tanaka, S. (2006). Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J. Biol. Chem. 281, 2120–2127.10.1074/jbc.M504988200Suche in Google Scholar PubMed

Huang, X.Y., Shi, G.M., and Devbhandari, R.P. (2012). Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection. PLoS One 7, e32775.10.1371/journal.pone.0032775Suche in Google Scholar PubMed PubMed Central

Hussain, M.M. (2001). Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front. Biosci. 6, D417–D428.10.2741/A619Suche in Google Scholar

Jaeger, L.B., Dohgu, S., and Hwang, M.C. (2009a). Testing the neurovascular hypothesis of Alzheimer’s disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-β protein, and impairs cognition. J. Alzheimers Dis. 17, 553–570.10.3233/JAD-2009-1074Suche in Google Scholar PubMed PubMed Central

Jaeger, L.B., Dohgu, S., and Sultana, R. (2009b). Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer’s disease. Brain Behav. Immun. 23, 507–517.10.1016/j.bbi.2009.01.017Suche in Google Scholar PubMed PubMed Central

Jickling, G.C., Liu, D.Z., and Stamova, B. (2014). Hemorrhagic transformation after ischemic stroke in animals and humans. J. Cereb. Blood Flow Metab. 34, 185–199.10.1038/jcbfm.2013.203Suche in Google Scholar PubMed PubMed Central

Jordan, J., Galindo, M.F., and Miller, R.J. (1998). Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18, 195–204.10.1523/JNEUROSCI.18-01-00195.1998Suche in Google Scholar

Kamino, M., Kishida, M., and Kibe, T. (2011). Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci. 102, 540–548.10.1111/j.1349-7006.2010.01815.xSuche in Google Scholar

Kook, S.Y., Hong, H.S., and Moon, M. (2012). Aβ(1–42)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling. J. Neurosci. 32, 8845–8854.10.1523/JNEUROSCI.6102-11.2012Suche in Google Scholar

Kounnas, M.Z., Henkin, J., Argraves, W.S. (1993). Low density lipoprotein receptor-related protein/α 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J. Biol. Chem. 268, 21862–21867.10.1016/S0021-9258(20)80620-6Suche in Google Scholar

Liu, J., Jin, X.C., and Liu, K.J. (2012). Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J. Neurosci. 32, 3044–3057.10.1523/JNEUROSCI.6409-11.2012Suche in Google Scholar PubMed PubMed Central

Lukes, A., Mun-Bryce, S., and Lukes, M. (1999). Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol. Neurobiol. 19, 267–284.10.1007/BF02821717Suche in Google Scholar PubMed

Marco, S. and Skaper, S.D. (2006). Amyloid β-peptide (1–42) alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci. Lett. 401, 219–224.10.1016/j.neulet.2006.03.047Suche in Google Scholar PubMed

Methia, N., Andre, P., and Hafezi-Moghadam, A. (2001). ApoE deficiency compromises the blood brain barrier especially after injury. Mol. Med. (Cambridge, MA) 7, 810–815.10.1007/BF03401973Suche in Google Scholar

Mulder, M., Blokland, A., and van den Berg, D.J. (2001). Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab. Invest. 81, 953–960.10.1038/labinvest.3780307Suche in Google Scholar PubMed

Nazer, B., Hong, S., and Selkoe, D.J. (2008). LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model. Neurobiol. Dis. 30, 94–102.10.1016/j.nbd.2007.12.005Suche in Google Scholar PubMed PubMed Central

Neels, J.G., van den Berg, B.M.M., and Lookene, A. (1999). The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties. J. Biol. Chem. 274, 31305–31311.10.1074/jbc.274.44.31305Suche in Google Scholar PubMed

Nishitsuji, K., Hosono, T., and Nakamura, T. (2011). Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier Model. J. Biol. Chem. 286, 17536–17542.10.1074/jbc.M111.225532Suche in Google Scholar

Nykjaer, A., Petersen, C.M., and Moller, B. (1992). Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. Evidence that the α2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267, 14543–14546.10.1016/S0021-9258(18)42072-8Suche in Google Scholar

Orth, K., Willnow, T., and Herz, J. (1994). Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator. J. Biol. Chem. 269, 21117–21122.10.1016/S0021-9258(17)31937-3Suche in Google Scholar

Pascale, C.L., Miller, M.C., and Chiu, C. (2011). Amyloid-β transporter expression at the blood-CSF barrier is age-dependent. Fluids Barriers CNS 8, 21.10.1186/2045-8118-8-21Suche in Google Scholar

Pflanzner, T., Janko, M.C., and Andre-Dohmen, B. (2011). LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier. Neurobiol. Aging 32, 2323.e1–11.10.1016/j.neurobiolaging.2010.05.025Suche in Google Scholar

Polavarapu, R., Gongora, M.C., and Yi, H. (2007). Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 109, 3270–3278.10.1182/blood-2006-08-043125Suche in Google Scholar

Proulx, D.P., Rouleau, P., and Pare, I. (2012). Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: a role for transcytosis across the blood brain barrier? J. Neuroimmunol. 251, 39–44.10.1016/j.jneuroim.2012.06.009Suche in Google Scholar

Qiu, Z.H., Strickland, D.K., and Hyman, B.T. (1999). α2-Macroglobulin enhances the clearance of endogenous soluble β-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J. Neurochem. 73, 1393–1398.10.1046/j.1471-4159.1999.0731393.xSuche in Google Scholar

Qosa, H., Abuznait, A.H., and Hill, R.A. (2012). Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer’s disease. J. Alzheimers Dis. 31, 151–165.10.3233/JAD-2012-120319Suche in Google Scholar

Quax, P.H.A., deBart, A.C.W., and Schalken, J.A. (1997). Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo. Prostate 32, 196–204.10.1002/(SICI)1097-0045(19970801)32:3<196::AID-PROS6>3.0.CO;2-JSuche in Google Scholar

Reijerkerk, A., Kooij, G., and van der Pol, S.M.A. (2006). Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 20, 2550.10.1096/fj.06-6099fjeSuche in Google Scholar

Rosenberg, G.A. and Yang, Y. (2007). Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg. Focus 22, E4.10.3171/foc.2007.22.5.5Suche in Google Scholar

Saunders, A.M., Strittmatter, W.J., and Schmechel, D. (1993). Association of apolipoprotein-E allele epsilon-4 with late-onset familial and sporadic Alzheimers disease. Neurology 43, 1467–1472.10.1212/WNL.43.8.1467Suche in Google Scholar

Schreibelt, G., Kooij, G., and Reijerkerk, A. (2007). Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 21, 3666–3676.10.1096/fj.07-8329comSuche in Google Scholar

Selkoe, D.J. (1998). The cell biology of β-amyloid precursor protein and presenilin in Alzheimer’s disease. Trends Cell Biol. 8, 447–453.10.1016/S0962-8924(98)01363-4Suche in Google Scholar

Selvais, C., D’Auria, L., and Tyteca, D. (2011). Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function. FASEB J. 25, 2770–2781.10.1096/fj.10-169508Suche in Google Scholar PubMed PubMed Central

Shibata, M., Yamada, S., and Kumar, S.R. (2000). Clearance of Alzheimer’s amyloid-β (1–40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489–1499.10.1172/JCI10498Suche in Google Scholar PubMed PubMed Central

Singh, I., Sagare, A.P., and Coma, M. (2013). Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance. Proc. Natl. Acad. Sci. USA 110, 14771–14776.10.1073/pnas.1302212110Suche in Google Scholar PubMed PubMed Central

Solito, R., Corti, F., and Chen, C.H. (2013). Mitochondrial aldehyde dehydrogenase-2 activation prevents beta-amyloid-induced endothelial cell dysfunction and restores angiogenesis. J. Cell Sci. 126, 1952–1961.10.1242/jcs.117184Suche in Google Scholar

Strickland, D.K., Au, D.T., and Cunfer, P. (2014). Low-density lipoprotein receptor-related protein-1 role in the regulation of vascular integrity. Arterioscler. Thromb. Vasc. Biol. 34, 487–498.10.1161/ATVBAHA.113.301924Suche in Google Scholar PubMed PubMed Central

Suzuki, Y., Nagai, N., and Yamakawa, K. (2009). Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein. Blood 114, 3352–3358.10.1182/blood-2009-02-203919Suche in Google Scholar PubMed

Teesalu, T., Hinkkanen, A.E., and Vaheri, A. (2001). Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am. J. Pathol. 159, 2227–2237.10.1016/S0002-9440(10)63073-8Suche in Google Scholar

Thomas, F.C., Taskar, K., and Rudraraju, V. (2009). Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm. Res. 26, 2486–2494.10.1007/s11095-009-9964-5Suche in Google Scholar PubMed PubMed Central

Tu, X.K., Yang, W.Z., and Liang, R.S. (2011). Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem. Res. 36, 2022–2028.10.1007/s11064-011-0526-ySuche in Google Scholar PubMed

Vajtr, D., Benada, O., and Kukacka, J. (2009). Correlation of ultrastructural changes of endothelial cells and astrocytes occurring during blood brain barrier damage after traumatic brain injury with biochemical markers of blood brain barrier leakage and inflammatory response. Physiol. Res. 58, 263–268.10.33549/physiolres.931253Suche in Google Scholar PubMed

Van den Steen, P.E., Van Aelst, I., and Hvidberg, V. (2006). The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. J. Biol. Chem. 281, 18626–18637.10.1074/jbc.M512308200Suche in Google Scholar PubMed

Vivien, D., Gauberti, M., and Montagne, A. (2011). Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J. Cereb. Blood Flow Metab. 31, 2119–2134.10.1038/jcbfm.2011.127Suche in Google Scholar PubMed PubMed Central

Wan, W.B., Cao, L., and Liu, L.M. (2014a). EGb761 Provides a protective effect against Aβ(1–42) oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model. PLoS One 9, e113126.10.1371/journal.pone.0113126Suche in Google Scholar PubMed PubMed Central

Wan, W.B., Chen, H.X., and Li, Y.M. (2014b). The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer’s disease. Int. J. Neurosci. 124, 75–81.10.3109/00207454.2013.825258Suche in Google Scholar PubMed

Wan, W.B., Cao, L., and Liu, L.M. (2015). A (1–42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J. Neurochem. 134, 382–393.10.1111/jnc.13122Suche in Google Scholar PubMed

Wang, H. and Eckel, R.H. (2014). What are lipoproteins doing in the brain? Trends Endocrinol. Metab. 25, 8–14.10.1016/j.tem.2013.10.003Suche in Google Scholar PubMed PubMed Central

Wang, Z., Meng, C.J., and Shen, X.M. (2012). Potential contribution of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J. Mol. Neurosci. 48, 273–280.10.1007/s12031-012-9769-6Suche in Google Scholar PubMed

Wei, X.L., Zhan, C.Y., and Chen, X.S. (2014). Retro-inverso isomer of angiopep-2: a stable D-Peptide ligand inspires brain-targeted drug delivery. Mol. Pharm. 11, 3261–3268.10.1021/mp500086eSuche in Google Scholar PubMed

Wild, J.B., Stather, P.W., and Sylvius, N. (2012). Low density lipoprotein receptor related protein 1 and abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 44, 127–132.10.1016/j.ejvs.2012.05.009Suche in Google Scholar PubMed

Xin, H.L., Jiang, X.Y., and Gu, J.J. (2011). Angiopep-conjugated poly (ethylene glycol)-co-poly (epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32, 4293–4305.10.1016/j.biomaterials.2011.02.044Suche in Google Scholar PubMed

Xin, H.L., Sha, X.Y., and Jiang, X.Y. (2012). Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials 33, 8167–8176.10.1016/j.biomaterials.2012.07.046Suche in Google Scholar PubMed

Xu, L., Cao, F., and Xu, F. (2015). Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats. PLoS One 10, e0122744.10.1371/journal.pone.0122744Suche in Google Scholar PubMed PubMed Central

Yang, Z.T., Strickland, D.K., and Bornstein, P. (2001). Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J. Biol. Chem. 276, 8403–8408.10.1074/jbc.M008925200Suche in Google Scholar PubMed

Yang, Y., Estrada, E.Y., and Thompson, J.F. (2007). Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27, 697–709.10.1038/sj.jcbfm.9600375Suche in Google Scholar PubMed

Yang, Y., Thompson, J.F., and Taheri, S. (2013). Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. J. Cereb. Blood Flow Metab. 33, 1104–1114.10.1038/jcbfm.2013.56Suche in Google Scholar PubMed PubMed Central

Yepes, M., Sandkvist, M., and Moore, E.G. (2003). Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112, 1533–1540.10.1172/JCI200319212Suche in Google Scholar

Zhang, X., Polavarapu, R., and She, H. (2007). Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-κB pathway activation. Am. J. Pathol. 171, 1281–1290.10.2353/ajpath.2007.070472Suche in Google Scholar PubMed PubMed Central

Zhang, C., An, J., and Haile, W.B. (2009). Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain. J. Cereb. Blood Flow Metab. 29, 1946–1954.10.1038/jcbfm.2009.174Suche in Google Scholar PubMed

Zheng, M.H., Wei, J.J., and Tang, Y.L. (2014). ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9. J. Mol. Neurosci. 54, 282–290.10.1007/s12031-014-0291-xSuche in Google Scholar PubMed

Zlokovic, B.V. (2008). The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178–201.10.1016/j.neuron.2008.01.003Suche in Google Scholar PubMed

Zlokovic, B.V., Deane, R., and Sagare, A.P. (2010). Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β-peptide elimination from the brain. J. Neurochem. 115, 1077–1089.10.1111/j.1471-4159.2010.07002.xSuche in Google Scholar PubMed PubMed Central